IL10: the intestinal immune brake
Function
IL10 encodes a cytokine that limits excessive inflammatory programs, including antigen-presentation and pro-inflammatory cytokine output, while supporting aspects of B-cell biology. Its receptor activates JAK–STAT signaling. The NCBI Gene summary highlights its essential intestinal immunoregulatory role in knockout studies.
IL-10 signaling
Immune activation is restrained; tissue-damaging responses can resolve.
→
IL-10 pathway lost
Uncontrolled intestinal inflammation can follow; human IL-10/IL-10R defects cause severe early-onset enterocolitis.
How to read this study’s methylation signal
The presentation lists IL10 among hypomethylated immune genes in severe UC. That does not guarantee more IL10 RNA or protein: the result depends on CpG location, responding cell type, and immune-cell abundance. IL10 may rise as a compensatory brake during inflammation even when disease remains active.
Human causal evidence
The strongest evidence for pathway necessity is genetic rather than epigenetic. Biallelic IL10RA or IL10RB variants that abolished IL-10-induced STAT3 phosphorylation were identified in children with severe infantile-onset enterocolitis; patient immune cells released excessive inflammatory cytokines (Glocker, Kotlarz, Boztug, and others, 2009). These rare monogenic cases establish that intact IL-10 signaling is essential, but they should not be equated with common adult UC or with a modest IL10 DMR.
What to measure next
IL-10 concentration alone is insufficient because abundant ligand can coexist with receptor resistance. A useful paired assay would measure cell-specific IL10 transcription, secreted protein, IL10RA/IL10RB abundance, and phospho-STAT3 after ex vivo stimulation. That separates compensatory production from effective anti-inflammatory signaling.